Company Overview and News

1
Comcast: Holding Together A Fragmented Future Media Landscape

53m seekingalpha
Comcast can remain relevant in a new media world of streaming and content democratization as a strong internet service provider.
CCV.CL CCV CMCSA TWX CCZ TWC CMCSK

17
Comcast says its fastest internet reaches more US homes than any other provider

2018-10-19 channelnewsasia
REUTERS: Comcast Corp said on Thursday that its fastest-speed gigabit internet service now reaches more homes than any other provider in the United States after it completed rollout to nearly all 58 million homes and businesses it serves.
CCV.CL CCV CMCSA TWX CCZ TWC CMCSK DIS

7
Internet provider groups sue Vermont over net neutrality law

2018-10-19 reuters
WASHINGTON (Reuters) - Five industry groups representing major internet providers and cable companies filed suit on Thursday seeking to block a Vermont law barring companies that do not abide by net neutrality rules from receiving state contracts.
FB CCV.CL GOOGL CCV CMCSA VZ CCZ GOOG CMCSK VZA

7
Internet provider groups sue Vermont over net neutrality law

2018-10-19 channelnewsasia
Four industry groups representing major internet providers and cable companies filed suit on Thursday seeking to block Vermont's state law barring companies that do not abide by net neutrality rules from receiving state contracts.
FB CCV.CL GOOGL CCV CMCSA VZ CCZ GOOG CMCSK VZA

16
Netflix soars as blistering subscriber growth restores faith

2018-10-17 nzherald.co.nz
Netflix is growing faster than even its most bullish fans on Wall Street predicted, soothing doubts about its global prospects and sending its already-stratospheric stock higher.
FORR CCV.CL CCV CMCSA CCZ CMCSK DIS

16
Netflix stock soars as roaring subscriber growth restores faith

2018-10-17 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
FORR CCV.CL CCV CMCSA NFLX CCZ CMCSK DIS

23
‘First Man’ blasts off behind ‘Venom,’ ‘A Star Is Born’

2018-10-14 entertainment.inquirer.net
This image released by Universal Pictures shows Ryan Gosling in a scene from “First Man.” (Universal Pictures via AP)
VIA LGF CCV CMCSA TWX CCZ SNEJF TWC AMCX VIAB CCV.CL LGF.A SNE LGF.B CMCSK DIS

 
‘First Man’ can’t beat ‘Venom,’ ‘A Star Is Born’ in box-office debut

2018-10-14 marketwatch
“First Man” was only good enough for third place in its opening weekend, as “Venom” and “A Star Is Born” again took the top two spots at the box office.
CCV.CL CCV CMCSA CCZ CMCSK

8
US defends FCC's repeal of net neutrality rules

2018-10-12 channelnewsasia - 1
The Trump administration defended the Federal Communications Commission repeal of landmark open internet rules known as net neutrality, urging a federal appeals court to reject a challenge.
FB CCV.CL GOOGL CCV CMCSA VZ CCZ GOOG CMCSK VZA

8
U.S. defends FCC's repeal of net neutrality rules

2018-10-12 reuters - 1
WASHINGTON, Oct 12 (Reuters) - The Trump administration defended the Federal Communications Commission repeal of landmark open internet rules known as net neutrality, urging a federal appeals court to reject a challenge.
FB CCV.CL GOOGL CCV CMCSA VZ CCZ GOOG CMCSK VZA

5
Capitol Report: Corporate America begins to distance itself from Saudi money due to Khashoggi affair

2018-10-11 marketwatch - 1
As the outcry grows over the alleged murder of Washington Post columnist Jamal Khashoggi by Saudi Arabian agents, some U.S. companies are cutting ties with the wealthy Middle Eastern nation — and more could follow suit.
BLK CCV.CL GOOGL CCV CMCSA AAPL RTN CCZ NYTAB GOOG CMCSK

18
FT says James Murdoch in line for Tesla chair. Musk reply: incorrect

2018-10-11 reuters
SAN FRANCISCO/BOSTON (Reuters) - Elon Musk replied with a Tweet saying: “This is incorrect” after the Financial Times reported that outgoing Twenty-First Century Fox Inc Chief Executive James Murdoch was the lead candidate to replace him as Tesla Inc chairman.
GJV FOX NWSA NWS CCV.CL CCV CMCSA CCZ FOXA CMCSK DIS

18
James Murdoch in line to replace Elon Musk as Tesla chairman: Report

2018-10-11 moneycontrol
Outgoing Twenty-First Century Fox Inc Chief Executive James Murdoch is the lead candidate to replace Elon Musk as Tesla Inc chairman, the Financial Times reported on Wednesday, citing two people briefed on the discussions.
GJV FOX NWSA NWS CCV.CL CCV CMCSA CCZ FOXA CMCSK DIS

18
FT says Murdoch in line for Tesla chair. Musk reply - incorrect

2018-10-11 channelnewsasia
Outgoing Twenty-First Century Fox Inc Chief Executive James Murdoch is the lead candidate to replace Elon Musk as Tesla Inc chairman, the Financial Times reported on Wednesday, citing two people briefed on the discussions.
GJV FOX NWSA NWS CCV.CL CCV CMCSA CCZ FOXA CMCSK DIS

18
FT says Murdoch in line for Tesla chair. Musk reply: incorrect

2018-10-11 channelnewsasia
Outgoing Twenty-First Century Fox Inc Chief Executive James Murdoch is the lead candidate to replace Elon Musk as Tesla Inc chairman, the Financial Times reported on Wednesday, but Musk in a tweeted reply to the newspaper said, "This is incorrect."
GJV FOX NWSA NWS CCV.CL CCV CMCSA CCZ FOXA CMCSK DIS

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to CMCSK / Comcast Corporation on message board site Silicon Investor.

Comcast Comcast Comcast CMCSK--Bill Gateu0027s beloved cable co. CMCSK--Bill Gateu0027s beloved cable co. CMCSK--Bill Gateu0027s beloved cable co.
CMCSK- Comcast - Spinoff and Tracking Stock Coming? CMCSK- Comcast - Spinoff and Tracking Stock Coming? CMCSK- Comcast - Spinoff and Tracking Stock Coming?
CUSIP: 20030N200